Apimeds Pharmaceuticals US (APUS) vs Soligenix (SNGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Soligenix is the larger company by market cap ($7.9 million vs $7.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APUS | SNGX |
|---|---|---|
| Share price | $5.02 | $0.3636 |
| Market cap | $7.58M | $7.91M |
| 1-day change | -8.89% | +4.90% |
| YTD return | -69.39% | — |
| 1-year return | -73.01% | — |
| EPS (TTM) | $-32.83 | $-0.83 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $59.70 | $1.80 |
| 52-week low | $1.51 | $0.28 |
| Distance from 52-week high | -91.59% | -79.80% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +279.54% |
| Average volume | 3.67M | 249.87K |
| Shares outstanding | 1.51M | 21.77M |
| Employees | — | 13 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Apimeds Pharmaceuticals US
APUS stock →Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure.
Health Care · Biotechnology: Pharmaceutical Preparations
About Soligenix
SNGX stock →Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions.
Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees
APUS vs SNGX FAQ
Which is bigger, Apimeds Pharmaceuticals US or Soligenix?
Soligenix (SNGX) is larger, with a market capitalization of $7.91M compared with $7.58M for Apimeds Pharmaceuticals US (APUS).
Are Apimeds Pharmaceuticals US and Soligenix in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.